Free Trial

agilon health's (AGL) "Market Perform" Rating Reiterated at JMP Securities

agilon health logo with Medical background

agilon health (NYSE:AGL - Get Free Report)'s stock had its "market perform" rating reaffirmed by stock analysts at JMP Securities in a report issued on Monday,Benzinga reports.

A number of other equities analysts also recently weighed in on AGL. Stifel Nicolaus raised their target price on shares of agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a research note on Wednesday, February 26th. Cowen reaffirmed a "hold" rating on shares of agilon health in a research report on Tuesday, April 15th. Royal Bank of Canada boosted their target price on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a report on Wednesday, February 26th. Needham & Company LLC restated a "hold" rating on shares of agilon health in a report on Friday, March 21st. Finally, Robert W. Baird dropped their price target on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, agilon health currently has a consensus rating of "Hold" and an average target price of $4.81.

View Our Latest Analysis on AGL

agilon health Stock Down 0.1 %

Shares of NYSE:AGL traded down $0.01 during midday trading on Monday, reaching $3.90. The company's stock had a trading volume of 575,352 shares, compared to its average volume of 5,879,061. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a 50 day moving average of $4.19 and a 200-day moving average of $3.14. The firm has a market capitalization of $1.61 billion, a P/E ratio of -4.14 and a beta of 0.38. agilon health has a 12-month low of $1.50 and a 12-month high of $7.73.

Hedge Funds Weigh In On agilon health

Several institutional investors have recently made changes to their positions in the business. KBC Group NV purchased a new stake in agilon health during the first quarter valued at approximately $70,000. Ridgecrest Wealth Partners LLC bought a new stake in shares of agilon health during the 1st quarter valued at $65,000. Wealth Enhancement Advisory Services LLC increased its stake in shares of agilon health by 21.8% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 99,697 shares of the company's stock worth $432,000 after purchasing an additional 17,866 shares in the last quarter. SG Americas Securities LLC raised its holdings in agilon health by 1,271.3% in the 1st quarter. SG Americas Securities LLC now owns 144,189 shares of the company's stock worth $624,000 after purchasing an additional 133,674 shares during the period. Finally, Simplicity Wealth LLC purchased a new position in agilon health during the first quarter valued at $186,000.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Analyst Recommendations for agilon health (NYSE:AGL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines